COSMOS Pharmaceutical Corporation

3349

JP3298400007

Drug Retailers

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
14,390 ^JPY	-0.79%		-0.28%	-11.64%

Apr. 12	Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	MT
Apr. 12	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	CI

COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024

January 12, 2024 at 01:00 am EST

COSMOS Pharmaceutical Corporation announced dividend of JPY 60.00 per share for the second quarter end of fiscal year ending May 31, 2024 compared to JPY 42.50 per share paid a year ago. Scheduled date of commencing dividend payments: February 13, 2024.

For the fiscal year ending May 31, 2024, the company expects year-end dividend of JPY 60.00 per share compared to JPY 57.50 per share paid a year ago.

Latest news about COSMOS Pharmaceutical Corporation

Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	Apr. 12	MT
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	Apr. 12	CI
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	Jan. 12	MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	Jan. 12	CI
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024	Jan. 12	CI
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores	23-10-12	MT
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023	23-10-11	CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	23-10-11	CI
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023	23-07-10	MT
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024	23-07-10	CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	23-07-10	CI
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings	23-04-11	MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	23-04-10	CI
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023	23-04-10	CI
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy	23-01-15	MT
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter of Fiscal 2023; Provides Dividend Guidance for the Full Year of Fiscal Year Ending May 31, 2023	23-01-13	CI
Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023	23-01-13	CI
Cosmos Pharma Clocks Higher Profit, Revenue in Fiscal Q1 on New Store Openings	22-10-12	MT
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Second Quarter-End and Full Year of Fiscal Year Ending May 31, 2023	22-10-11	CI
UBS Adjusts COSMOS Pharmaceutical’s Price Target to 15,500 Yen From 16,500 Yen, Keeps at Neutral	22-08-12	MT
Cosmos Pharmaceutical Logs Lower Profit in FY22 Despite Jump in Net Sales; Shares Climb 6%	22-07-12	MT
COSMOS Pharmaceutical Corporation Announces Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending May 31, 2023	22-07-11	CI
UBS Adjusts Cosmos Pharmaceutical's Price Target to 16,500 Yen From 17,500 Yen, Keeps at Neutral	22-03-28	MT
Global markets live: Baidu, Cisco, Nvidia, Amazon, Apple...	21-11-18
COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings	21-07-13	RE

Chart COSMOS Pharmaceutical Corporation

Duration

Period

More charts

Company Profile

COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. It also provides tobacco and others.

Sector

Drug Retailers

Calendar

2024-05-29 - Final dividend

More about the company

Income Statement Evolution

More financial data

Ratings for COSMOS Pharmaceutical Corporation

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14,390 JPY

Average target price

16,620 JPY

Spread / Average Target

+15.50%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs with Grocery

	1st Jan change	Capi.
COSMOS PHARMACEUTICAL CORPORATION	-11.64%	3.62B
SUNDRUG CO.,LTD.	-0.09%	3.36B
TSURUHA HOLDINGS INC.	-23.44%	3.06B
LBX PHARMACY CHAIN	+7.46%	2.59B
KUSURI NO AOKI HOLDINGS CO., LTD.	-9.26%	1.75B
CREATE SD HOLDINGS CO., LTD.	+9.30%	1.35B
GREAT TREE PHARMACY CO., LTD.	-20.60%	957M
SHUYU CIVILIAN PHARMACY CORP., LTD.	-38.42%	704M
FARMACIAS BENAVIDES, S.A.B. DE C.V.	-0.53%	450M
CAWACHI LIMITED	-1.85%	370M

Retail - Drugs with Grocery